![]() |
 |
Articles provided on this website or that are linked to or from this website are owned by third parties and protected by copyright laws. Authorized users have permission to download, display, view and print a single copy for their personal use for research and private study purposes. Any other use is prohibited unless permission is obtained from the copyright owner. Authorized users may not remove, alter, or modify any part of the article, including the authors' names and copyright notices.
|
|
|
| ASTHMA WITH ALLERGIC RHINITIS |
|
The effect of montelukast on rhinitis symptons in patients with asthma and seasonal allergic rhinitis
Philip G et al Curr Med Res Opin
2004;20(8):1549–1558.
|
|
|
|
|
|
Additional benefit of montelukast for asthma in patients with both asthma and allergic rhinitis: Analysis from the COMPACT Trial
Price DB et al Allergy Clin Immunol Int
Supplement 1(2003):29.
|
|
|
|
|
|
ARIA Guidelines
Allergic Rhinitis and its Impact on Asthma, World Health Organization
1999.
|
|
|
View Article
|
|
|
|
|
Diagnosis & Management Handbook - Chronic Airways Disease - A Guide for Primary Care Physicians
IPAG (International Primary Care Airways Group) IPAG Diagnosis & Management Handbook
2005;i–28.
|
|
|
|
View Article
|
|
|
|
|
Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults
Price DB et al Clin Exp Allergy
2005;35:282–287.
|
|
|
|
|
|
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the improving asthma control trial
Bousquet J et al Clin Exp Allergy
2005;35(6):723–727.
|
|
|
|
|
|
The MetaForum
Improving Outcomes for Asthma Patients with Allergic Rhinitis
MetaForum Outcomes newsletter, University of Southampton and International Primary Care Respiratory Group (IPCRG), London, UK, December 13, 2004.
|
|
|
|
View Article
|
|
|
|
|
Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial performed in the spring
Philip G et al Clin Exp Allergy
2002;32(7):1020–1028.
|
|
|
|
|
|
A review of montelukast in the treatment of asthma and allergic rhinitis
Nayak A Expert Opin Pharmacother
2004;5(3):679–686.
|
|
|
|
|
|
Allergic rhinitis and asthma: How important is the link?
Corren J J Allergy Clin Immunol
1997;99:S781–S786.
|
|
|
|
|
|
Allergic rhinitis: Systemic inflammation and implications for management
Borish L J Allergy Clin Immunol
2003;112:1021–1031.
|
|
|
|
|
|
|
| ASTHMA |
|
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
Vaquerizo MJ Thorax
2003;58:204–210.
|
|
|
|
|
|
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: One year, double blind, randomised, comparative trial
Bjermer L et al BMJ
2003;327:891–895.
|
|
|
|
|
|
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
Price DB Thorax
2003;58:211–216.
|
|
|
|
|
|
A comparison of the effect of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
Storms W et al Respir Med
2004;98:1051–1062.
|
|
|
|
|
|
The national montelukast survey
Barnes N et al J Allergy Clin Immunol
2005;115(1):47–54.
|
|
|
|
|
|
The MetaForum
Improving Asthma through More Effective Control of Inflammation: A European Consensus Conference
First MetaForum newsletter, Royal College of Physicians, London, UK, April 20–21, 2004.
|
|
|
|
View Article
|
|
|
|
|
Cysteinyl leukotrienes in allergic inflammation: Strategic target for therapy
Busse W et al Chest
2005;127(4):1312–1326.
|
|
|
|
|
|
Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists
Currie G et al Q J Med
2005;98:171–182.
|
|
|
|
|
|
Impact of montelukast on symptoms in mild-to-moderate persistent asthma and exercise-induced asthma: Results of the ASTHMA survey
Curr Med Res Opin Malonne H et al
2002;18(8):512–519.
|
|
|
|
|
|
Early intervention important in asthma — evidence increasing
Haahtela T Duodecim Medical Journal
2003;119:2025–2027.
|
|
|
|
|
|
Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial
Green RH et al Lancet
2002;360(9347):1715–21.
|
|
|
|
|
|
|
| ASTHMA IN KIDS |
|
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years
Knorr B et al Pediatrics
2001;108:E48.
|
|
|
|
|
|
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma
Bisgaard H Am J Respir Crit Care Med
2005;171(4):315–322.
|
|
|
|
|
|
The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old
Straub D et al Chest
2005;127(2):509–514.
|
|
|
|
|
|
Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction
Kim J et al Pediatr Pulmonol
2005;39:162–166.
|
|
|
|
|
|
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma
Kemp J Pediatr
1998;133(3):424–428.
|
|
|
|
|
|
"Real-world" effectiveness of daily controller medicine in children with mild persistent asthma
Bukstein D et al Ann Allergy Asthma Immunol
2003;90:543–549.
|
|
|
|
|
|
Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: Results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy
Maspero J et al Curr Med Res Opin
2001;17(2):96–104.
|
|
|
|
|
|
